Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion evidence source_evidence_literature NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion SIO_000772 25468223 NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion wasDerivedFrom befree-20150227 NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion wasGeneratedBy ECO_0000203 NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.